About Company
Reglagene is a preclinical stage oncology therapeutics company developing new medicines that fight cancer safely. Despite advancements in cancer's early detection and therapy, 62% of patients with Stage II-IV cancers still receive chemotherapy as frontline treatment, and 86% of those patients report side effects and toxicities. By targeting unique structures in DNA, Reglagene can fix the decades old problem of toxic cancer treatments, and bring forward safe, efficacious therapies.
